Determine the necessary mass, volume, or concentration for preparing a solution.
| Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
|---|
Information
ARV-825 is a BRD4 Inhibitor that recruits BRD4 to the E3 ubiquitin ligase cereblon, leading to fast, efficient, and prolonged degradation of BRD4 and sustained down-regulation of MYC.
Targets
BRD4 BD2 (Cell-free assay); BRD4 BD1 (Cell-free assay) 28 nM(Kd); 90 nM(Kd)
In vitro
Compared with the BRD4 inhibitors, ARV-825 treatment results in a strikingly more pronounced effect on the levels of c-MYC, and downstream cell proliferation and apoptosis induction in BL (Burkitt’s Lymphoma) cell lines. The IC50s of ARV-825 for all tested cell lines and primary AML cells at 72 hours are in the low nanomolar range (2-50 nM). ARV-825 treatment reduces PIM1 levels and phosphorylation of CXCR4 in AML cells while overexpression of PIM1 or Myc reverses the phenomena.
In vivo
In a mouse model of human leukemia, the leukemia burdens are significantly lower in the ARV-825 treated mice as confirmed by luciferase imaging, flow cytometry, spleen size and survived longer compared to control mice.
Cell Research(from reference)
Cell lines:RS4;11 cells
Concentrations:3, 10, 30 nM
Incubation Time:3 h
Taxonomy Tree
| Kingdom | Organic compounds |
|---|---|
| Superclass | Organoheterocyclic compounds |
| Class | Isoindoles and derivatives |
| Subclass | Isoindolines |
| Intermediate Tree Nodes | Isoindolones |
| Direct Parent | Phthalimides |
| Alternative Parents | Alpha amino acids and derivatives Thienodiazepines Anilides Isoindoles N-arylamides Phenol ethers Phenoxy compounds Piperidinediones Secondary alkylarylamines Alkyl aryl ethers Chlorobenzenes Delta lactams 1,4-diazepines Aryl chlorides N-substituted carboxylic acid imides Vinylogous amides Triazoles Dicarboximides Heteroaromatic compounds Thiophenes N-unsubstituted carboxylic acid imides Secondary carboxylic acid amides Ketimines Dialkyl ethers Propargyl-type 1,3-dipolar organic compounds Azacyclic compounds Organic oxides Organochlorides Carbonyl compounds Hydrocarbon derivatives Organopnictogen compounds |
| Molecular Framework | Aromatic heteropolycyclic compounds |
| Substituents | Phthalimide - Thieno-para-diazepine - Alpha-amino acid or derivatives - Isoindole - Anilide - Piperidinedione - Phenoxy compound - Phenol ether - N-arylamide - Piperidinone - Secondary aliphatic/aromatic amine - Para-diazepine - Alkyl aryl ether - Halobenzene - Delta-lactam - Chlorobenzene - Aryl halide - Benzenoid - Monocyclic benzene moiety - Piperidine - Aryl chloride - Carboxylic acid imide, n-substituted - Azole - Heteroaromatic compound - Carboxylic acid imide - Vinylogous amide - Dicarboximide - 1,2,4-triazole - Carboxylic acid imide, n-unsubstituted - Thiophene - Secondary carboxylic acid amide - Lactam - Ketimine - Carboxamide group - Amino acid or derivatives - Secondary amine - Propargyl-type 1,3-dipolar organic compound - Carboxylic acid derivative - Azacycle - Dialkyl ether - Ether - Organic 1,3-dipolar compound - Hydrocarbon derivative - Carbonyl group - Organic oxygen compound - Organic nitrogen compound - Organic oxide - Organopnictogen compound - Organooxygen compound - Amine - Organonitrogen compound - Imine - Organochloride - Organohalogen compound - Aromatic heteropolycyclic compound |
| Description | This compound belongs to the class of organic compounds known as phthalimides. These are aromatic heterocyclic compounds containing a 1,3-dioxoisoindoline moiety. They are imide derivatives of phthalic anhydrides. |
| External Descriptors | Not available |
| Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
|---|
| Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Find and download the COA for your product by matching the lot number on the packaging.
| Lot Number | Certificate Type | Date | Item |
|---|---|---|---|
| Certificate of Analysis | Feb 26, 2024 | A413965 | |
| Certificate of Analysis | Feb 26, 2024 | A413965 | |
| Certificate of Analysis | Feb 26, 2024 | A413965 | |
| Certificate of Analysis | Feb 26, 2024 | A413965 | |
| Certificate of Analysis | Feb 26, 2024 | A413965 | |
| Certificate of Analysis | Feb 26, 2024 | A413965 | |
| Certificate of Analysis | Feb 26, 2024 | A413965 | |
| Certificate of Analysis | Feb 26, 2024 | A413965 | |
| Certificate of Analysis | Feb 26, 2024 | A413965 | |
| Certificate of Analysis | Feb 26, 2024 | A413965 |
| Solubility | Solubility (25°C) In vitro DMSO: 100 mg/mL (108.29 mM); Ethanol: 3 mg/mL (3.24 mM); Water: Insoluble; |
|---|---|
| Molecular Weight | 923.4 |
| XLogP3 | 4.800 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 14 |
| Rotatable Bond Count | 19 |
| Exact Mass | 922.288 Da |
| Monoisotopic Mass | 922.288 Da |
| Topological Polar Surface Area | 233.000 Ų |
| Heavy Atom Count | 65 |
| Formal Charge | 0 |
| Complexity | 1720.000 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| The total count of all stereochemical bonds | 0 |
| Covalently-Bonded Unit Count | 1 |